Search Within

Maura N Dickler

Formats
  1. Meeting Abstract (141)
  2. Journal Article (115)
  3. Book Section (5)
  4. Conference Paper (1)
  5. Review (1)
Groups
  1. Department of Medicine (169)
  2. Solid Tumor Oncology Division (163)
  3. Breast Medicine Service (155)
  4. Survivorship Research (152)
  5. Epidemiology and Biostatistics (105)
  6. Population Sciences Research Program (89)

More Groups

People
  1. Clifford Hudis (102)
  2. Larry Norton (64)
  3. Shari Goldfarb (51)
  4. Chau Dang (39)
  5. Sujata Patil (35)
  6. Tiffany Traina (34)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2020 (6)
  4. 2019 (4)
  5. 2018 (20)
  6. 2017 (29)

More Years

Publications
  1. Journal of Clinical Oncology (69)
  2. Cancer Research (41)
  3. Breast Cancer Research and Treatment (18)
  4. Clinical Cancer Research (14)
  5. Annals of Oncology (10)
  6. Journal of Sexual Medicine (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (70)
  2. American Association for Cancer Research (57)
  3. Springer (26)
  4. Elsevier Inc. (18)
  5. Oxford University Press (18)
  6. Elsevier Science, Inc. (7)

More Publishers

Results (263)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer
    Journal Article

    Dickler, M. N.; Cobleigh, M. A.; Miller, K. D.; Klein, P. M.; Winer, E. P.
    Breast Cancer Research and Treatment (2009)

    Fulltext@MSK | Save
  • Hepatitis C virus infection does not preclude standard breast cancer-directed therapy
    Journal Article

    D'Angelo, S.; Deutscher, M.; Dickler, M.; Weinstock, D.
    Clinical Breast Cancer (2009)

    Fulltext@MSK | Save
  • Limited complications from breast cancer treatment in women with chronic hepatitis C virus infection
    Meeting Abstract

    D'Angelo, S.; Deutscher, M.; Dickler, M. N.; Weinstock, D. M.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • WNK1 haplotypes and bevacizumab-induced hypertension
    Meeting Abstract

    Frey, M. K.; Olvera, N.; Bogomolniy, F.; Dao, F.; Borsu, L.; Konner, J. A.; Rizvi, N. A.; Barakat, R. R.; Dickler, M. N.; Levine, D. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Tolerance of bevacizumab in an older patient population: The Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Richardson, S.; Dickler, M. N.; Dang, C. T.; Hudis, C. A.; Traina, T. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Osteonecrosis of the jaw (ONJ) among intravenous (IV) bisphosphonate- and/or bevacizumab-treated patients (pts) at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    McArthur, H. L.; Estilo, C.; Huryn, J.; Williams, T.; Fornier, M.; Traina, T. A.; Howard, J.; Hudis, C. A.; Dickler, M. N.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Incidence and severity of sensory neuropathy (SN) with bevacizumab (B) added to dose-dense (dd) doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound (nab) paclitaxel (P) in patients (pts) with early stage breast cancer (BC)
    Meeting Abstract

    Sierecki, M. R.; Rugo, H. S.; McArthur, H. L.; Traina, T. A.; Paulson, M.; Rourke, M.; Norton, L.; Seidman, A. D.; Hudis, C. A.; Dickler, M. N.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Dose-dense (dd) doxorubicin-cyclophosphamide (AC) X 4 and short-term changes in left ventricular ejection fraction (LVEF) alone or with bevacizumab (B) in patients (pts) with early stage breast cancer (BC)
    Meeting Abstract

    Morris, P. G.; Dickler, M. N.; McArthur, H. L.; Traina, T. A.; Nulsen, B.; Steingart, R. M.; Rugo, S.; Norton, L.; Hudis, C. A.; Dang, C. T.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Independent review of E2100 progression-free survival (PFS) with the addition of bevacizumab (B) to paclitaxel (P) as initial chemotherapy for metastatic breast cancer (MBC)
    Meeting Abstract

    Klencke, B. J.; Bhattacharya, S.; Samant, M. K.; Gralow, J. R.; Dickler, M. N.; Cobleigh, M. A.; Perez, E. A.; Shenkier, T. N.; Davidson, N. E.; Miller, K. D.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase II study of weekly nanoparticle albumin bound (nab)paclitaxel with carboplatin and trastuzumab as 1st-line therapy for HER2-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Seidman, A. D.; Conlin, A. K.; Bach, A.; Brufsky, A. M.; Saleh, M. N.; Lake, D.; Dickler, M. N.; D'Andrea, G.; Traina, T. A.; Hudis, C. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save